JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

Search

Option Care Health Inc

Suletud

SektorTervishoid

34.68 -1.81

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

34.44

Max

35.37

Põhinäitajad

By Trading Economics

Sissetulek

1.3M

52M

Müük

19M

1.4B

P/E

Sektori keskmine

28.738

90.422

Kasumimarginaal

3.611

Töötajad

8,000

EBITDA

53M

156M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+7.01% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

24. veebr 2026

Turustatistika

By TradingEconomics

Turukapital

1.3B

5.9B

Eelmine avamishind

36.49

Eelmine sulgemishind

34.68

Uudiste sentiment

By Acuity

33%

67%

78 / 352 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Option Care Health Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

28. jaan 2026, 23:51 UTC

Tulu

Correction to Samsung Fourth-Quarter Net Profit Article

28. jaan 2026, 23:49 UTC

Kuumad aktsiad

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

28. jaan 2026, 23:19 UTC

Tulu

Samsung's Fourth-Quarter Net Profit Beats Consensus

28. jaan 2026, 22:43 UTC

Tulu

Waste Management Logs Higher 4Q Profit as Revenue Rises

29. jaan 2026, 00:00 UTC

Omandamised, ülevõtmised, äriostud

Diller's Overture Came Before Warner Unveiled Split Plans, Source Says -- WSJ

29. jaan 2026, 00:00 UTC

Omandamised, ülevõtmised, äriostud

Warner Says CNN Wasn't and Isn't for Sale -- WSJ

29. jaan 2026, 00:00 UTC

Omandamised, ülevõtmised, äriostud

Barry Diller Told Warner Bros. Discovery He Is Interested in Buying CNN -- WSJ

29. jaan 2026, 00:00 UTC

Omandamised, ülevõtmised, äriostud

Barry Diller Approached Warner Bros. Discovery Last Year About Buying CNN, Sources Say -- WSJ

28. jaan 2026, 23:49 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

28. jaan 2026, 23:30 UTC

Market Talk

Tesla to Use Car Factory for Robot Aims -- Market Talk

28. jaan 2026, 23:28 UTC

Tulu

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

28. jaan 2026, 23:26 UTC

Tulu

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

28. jaan 2026, 23:21 UTC

Tulu

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28. jaan 2026, 23:18 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28. jaan 2026, 22:58 UTC

Tulu

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28. jaan 2026, 22:48 UTC

Market Talk

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

28. jaan 2026, 22:45 UTC

Tulu

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

28. jaan 2026, 22:44 UTC

Tulu

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

28. jaan 2026, 22:43 UTC

Tulu

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

28. jaan 2026, 22:41 UTC

Tulu
Kuumad aktsiad

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

28. jaan 2026, 22:41 UTC

Market Talk

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

28. jaan 2026, 22:41 UTC

Tulu

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

28. jaan 2026, 22:40 UTC

Tulu

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

28. jaan 2026, 22:39 UTC

Tulu

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

28. jaan 2026, 22:38 UTC

Tulu

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

28. jaan 2026, 22:37 UTC

Tulu

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

28. jaan 2026, 22:35 UTC

Tulu

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28. jaan 2026, 22:26 UTC

Market Talk
Tulu

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

28. jaan 2026, 22:20 UTC

Market Talk

Global Equities Roundup: Market Talk

28. jaan 2026, 22:20 UTC

Market Talk

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Option Care Health Inc Prognoos

Hinnasiht

By TipRanks

7.01% tõus

12 kuu keskmine prognoos

Keskmine 38.75 USD  7.01%

Kõrge 42 USD

Madal 36 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Option Care Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

10 ratings

9

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

31.11 / 32.41Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Neutral Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

78 / 352 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Option Care Health Inc

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
help-icon Live chat